Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Alnylam Pharmace. buy Chardan Capital

Alnylam Pharmace.
Start price
€229.30
02.05.25 / 50%
Target price
€287.76
02.05.26
Performance (%)
10.95%
End price
€254.40
03.05.26
Summary
This prediction ended on 03.05.26 with a price of €254.40. The prediction had a final performance of 10.95%. Chardan_Capital has a follow-up prediction for Alnylam Pharmace. where he still thinks Alnylam Pharmace. is a Buy. Chardan_Capital has 50% into this prediction

Alnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.

AI-generated
Performance without dividends (%)
Name 1w 1m 1y
Alnylam Pharmace. 6.396% 6.396% -49.210%
iShares Core DAX® 2.573% 3.502% 8.408%
iShares Nasdaq 100 4.858% 0.654% 28.383%
iShares Nikkei 225® 5.590% -0.246% 52.915%
iShares S&P 500 3.250% 2.083% 24.370%

Comments by Chardan_Capital for this prediction

In the thread Alnylam Pharmace. diskutieren
Prediction Buy
Perf. (%) 10.95%
Target price 287.755
Change
Ends at 02.05.26

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its price target raised by analysts at Chardan Capital from $300.00 to $325.00. They now have a "buy" rating on the stock.
Ratings data for ALNY provided by MarketBeat

Chardan Capital 
0
Report Share
02.05.25
In the thread Trading Alnylam Pharmace.
Prediction Buy
Perf. (%) 10.95%
Target price 287.755
Change
Ends at 02.05.26

Die von Chardan_Capital gewählte maximale Laufzeit wurde überschritten

Chardan Capital 
0
Report Share
03.05.26

Current prediction by Chardan_Capital for Alnylam Pharmace.

buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€281.10
25.03.26
€366.18
25.03.27
-32.53%
07.08.26

Chardan Capital 
25.03.26 50%

Stopped prediction by Chardan_Capital for Alnylam Pharmace.

buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€179.35
31.07.26
€369.24
31.07.27
5.74%
07.08.26

Chardan Capital 
31.07.26 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€236.90
26.02.25
€286.08
26.02.26
18.66%
27.02.26

Chardan Capital 
26.02.25 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€260.20
11.10.24
€274.17
11.10.25
52.23%
12.10.25

Chardan Capital 
11.10.24 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€139.00
16.02.24
€209.30
16.02.25
77.27%
17.02.25

Chardan Capital 
16.02.24 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€168.60
08.08.23
€228.30
08.08.24
46.56%
09.08.24

Chardan Capital 
08.08.23 50%